Hound Partners LLC Has $7.79 Million Stock Position in HCA Healthcare, Inc. $HCA

Hound Partners LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 42.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 18,265 shares of the company’s stock after selling 13,567 shares during the period. HCA Healthcare accounts for about 1.0% of Hound Partners LLC’s holdings, making the stock its 24th largest position. Hound Partners LLC’s holdings in HCA Healthcare were worth $7,785,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital World Investors grew its holdings in shares of HCA Healthcare by 3.8% during the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after purchasing an additional 179,443 shares in the last quarter. Norges Bank bought a new position in HCA Healthcare in the second quarter worth $1,152,408,000. Arrowstreet Capital Limited Partnership increased its holdings in HCA Healthcare by 1.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock valued at $880,199,000 after buying an additional 36,414 shares during the period. Viking Global Investors LP boosted its position in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Finally, Legal & General Group Plc raised its position in HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock worth $479,267,000 after purchasing an additional 8,478 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 15,214 shares of company stock worth $7,797,595 in the last ninety days. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 0.2%

HCA Healthcare stock opened at $533.39 on Monday. The stock has a market capitalization of $119.28 billion, a price-to-earnings ratio of 18.79, a P/E/G ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a 12-month low of $313.21 and a 12-month high of $556.52. The stock has a 50-day simple moving average of $507.05 and a 200 day simple moving average of $470.48.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on HCA shares. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. UBS Group upped their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Sanford C. Bernstein set a $541.00 target price on shares of HCA Healthcare in a research note on Monday, February 9th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Finally, Royal Bank Of Canada raised their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $537.73.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.